CIS IS A POTENT CHECKPOINT IN NK CELL ANTI-LEUKEMIA IMMUNITY

被引：0
|
作者：
Huntington, N. [1 ]
机构：
[1] Walter & Eliza Hall, Mol Immunol, Parkville, Vic, Australia
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S815
引用
收藏
页码：335 / 336
页数：2
相关论文
共 50 条
  • [31] MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
    Lee-Sherick, Alisa B.
    Jacobsen, Kristen M.
    Henry, Curtis J.
    Huey, Madeline G.
    Parker, Rebecca E.
    Page, Lauren S.
    Hill, Amanda A.
    Wang, Xiaodong
    Frye, Stephen, V
    Earp, H. Shelton
    Jordan, Craig T.
    DeRyckere, Deborah
    Graham, Douglas K.
    JCI INSIGHT, 2018, 3 (21):
  • [32] Targeting PRMT9 Elicits Cgas-Mediated Anti-Leukemia Immunity
    Dong, Haojie
    He, Xin
    Zhang, Lei
    Chen, Wei
    Lin, Yichun
    Liu, Songbai
    Wang, Huafeng
    Huang, Wenfeng
    Li, Sierra Min
    Zhu, Yinghui
    Zhao, Dandan
    Ghoda, Lucy
    Su, Rui
    Chen, Jianjun
    Sharma, Ritin
    Pirrotte, Patrick
    Wu, Xiwei
    Hu, Weidong
    Han, Weidong
    Shen, Binghui
    Kuo, Ya-Huei
    Jin, Jie
    Salhotra, Amandeep
    Wang, Jeffrey
    Marcucci, Guido
    Luo, Yun
    Li, Ling
    BLOOD, 2022, 140 : 4931 - 4933
  • [33] Dasatinib-loaded albumin nanoparticles possess diminished endothelial cell barrier disruption and retain potent anti-leukemia cell activity
    Dong, Chunling
    Li, Bo
    Li, Zhenyu
    Shetty, Sreerama
    Fu, Jian
    ONCOTARGET, 2016, 7 (31) : 49699 - 49709
  • [34] Mertk Inhibition Promotes Anti-Leukemia Immunity By Reversing T Cell Suppression Via the PD-1 Axis
    Lee-Sherick, Alisa
    Jacobsen, Kristen
    Henry, Curtis J.
    Parker, Rebecca
    Wang, Xiaodong
    Frye, Stephen V.
    Earp, H. Shelton
    DeRyckere, Deborah
    Graham, Douglas K.
    BLOOD, 2018, 132
  • [35] PLASMA-MEDIATED LEUKEMIA CELL DESTRUCTION - CONCENTRATION AND PURIFICATION OF ANTI-LEUKEMIA FACTOR
    KASSEL, RL
    OLD, LJ
    DAY, NK
    HARDY, WD
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1977, 155 (02): : 230 - 233
  • [36] Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
    Ganjalikhani-Hakemi, Mazdak
    Xu, Ling
    Zamyatnin, Andrey A., Jr.
    Bazhin, Alexandr V.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] ANTI-LEUKEMIA ACTIVITY OF PLASMA FIBRONECTIN
    MACEWEN, EG
    HAYES, A
    MOONEY, S
    JOHN, M
    OLD, LJ
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1982, 181 (03) : 275 - 275
  • [38] Long-lived donor-derived human memory-like NK cells with potent anti-leukemia activity as a novel cell therapy approach to control leukemia relapse after haploidentical HSCT
    Tanzi, Matteo
    Consonni, Michela
    Ferulli, Federica
    Turin, Ilaria
    Montini, Enrica
    Boghen, Stella
    Acquafredda, Gloria
    Compagno, Francesca
    Dellabona, Paolo
    Casorati, Giulia
    Zecca, Marco
    Montagna, Daniela
    BONE MARROW TRANSPLANTATION, 2018, 53 : 42 - 43
  • [39] Anti-leukemia selectivity in actinomycin analogues
    Takusagawa, F
    Carlson, RG
    Weaver, RF
    BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) : 719 - 725
  • [40] Leukemia specific complement dependent cytotoxicity contributes to anti-leukemia immunity induced by leukemia cell-derived HSP70 immunization in mice.
    Jimbo, J
    Sato, K
    Hosoki, T
    Shindo, M
    Ikuta, K
    Torimoto, Y
    Kohgo, Y
    BLOOD, 2005, 106 (11) : 58B - 58B
12345